about
Effects of Bariatric Surgery on Mortality in Swedish Obese SubjectsThe expression of inhibin beta B is high in human adipocytes, reduced by weight loss, and correlates to factors implicated in metabolic diseaseSemiparametric Bayesian commensurate survival model for post-market medical device surveillance with non-exchangeable historical dataRelations of adipose tissue CIDEA gene expression to basal metabolic rate, energy restriction, and obesity: population-based and dietary intervention studies.Efficacy of tiotropium in COPD patients with FEV1 ≥ 60% participating in the UPLIFT® trial.Bayesian adaptive design for device surveillance.Cell death-inducing DFF45-like effector C is reduced by caloric restriction and regulates adipocyte lipid metabolism.Adjusted P values for genome-wide scans.COPD in young patients: a pre-specified analysis of the four-year trial of tiotropium (UPLIFT).Effect of tiotropium in men and women with COPD: results of the 4-year UPLIFT trial.Differences in associations between HSD11B1 gene expression and metabolic parameters in subjects with and without impaired glucose homeostasis.Tiotropium as a first maintenance drug in COPD: secondary analysis of the UPLIFT trial.Preliminary report: Zn-alpha2-glycoprotein genotype and serum levels are associated with serum lipids.Long-term efficacy of tiotropium in relation to smoking status in the UPLIFT trial.Effect of tiotropium on outcomes in patients with moderate chronic obstructive pulmonary disease (UPLIFT): a prespecified subgroup analysis of a randomised controlled trial.LDL receptor but not apolipoprotein E deficiency increases diet-induced obesity and diabetes in mice.Mice deficient in apolipoprotein E but not LDL receptors are resistant to accelerated atherosclerosis associated with obesity.Acute hyperinsulinemia raises plasma interleukin-6 in both nondiabetic and type 2 diabetes mellitus subjects, and this effect is inversely associated with body mass index.Three definitions of the metabolic syndrome: relations to mortality and atherosclerotic morbidity.Dissociation between adipose tissue expression and serum levels of adiponectin during and after diet-induced weight loss in obese subjects with and without the metabolic syndrome.The expression of NAD(P)H:quinone oxidoreductase 1 is high in human adipose tissue, reduced by weight loss, and correlates with adiposity, insulin sensitivity, and markers of liver dysfunction.Separation of human adipocytes by size: hypertrophic fat cells display distinct gene expression.Impact of weight change, secular trends and ageing on cardiovascular risk factors: 10-year experiences from the SOS study.The use of virtual reality for training in carotid artery stenting: a construct validation study.Porcine transfer study: virtual reality simulator training compared with porcine training in endovascular novices.Postnatal testosterone exposure results in insulin resistance, enlarged mesenteric adipocytes, and an atherogenic lipid profile in adult female rats: comparisons with estradiol and dihydrotestosterone.A new rat model exhibiting both ovarian and metabolic characteristics of polycystic ovary syndrome.A microarray search for genes predominantly expressed in human omental adipocytes: adipose tissue as a major production site of serum amyloid A.Methods and Issues to Consider for Detection of Safety Signals From Spontaneous Reporting DatabasesRecent Statistical Contributions to Medical Device DevelopmentAssessment of a Virtual Interventional Simulator Trainer
P50
Q22250885-B530E6FE-892E-4B84-BF4B-A2B51E2AE080Q24323037-9C8C2FC4-DA67-4523-8AFB-266C0416D538Q30708681-40357FAF-B520-4A90-80D6-0DB06833EC27Q34693194-44C1D296-8BFC-4CAD-978A-8783A3BEE7DDQ37995347-EDF48900-0045-4E65-A81F-F62B5AAB2B9AQ39512723-826DB591-C77E-40AA-98D4-F1AFB87E2735Q42440258-313B8795-E770-45AA-A133-84FE9299E174Q42533782-3CF5D1A2-C1FE-4358-9821-96589F35386FQ42932043-99650CA2-78BF-4BED-AD11-34081B7DBD1BQ43086207-7BADC825-9915-451A-8BB3-A44FBA6D7428Q43104432-BA7F85F5-DEBA-4375-8AF1-79340FBDC1FEQ43149143-FAEDEA81-F230-44B0-A47F-E75738834F94Q43195498-0BA9F294-C4DC-4E1B-AA26-D03419C86992Q43283597-3194F05D-94E0-4CF4-BAB5-374EC846923DQ43283807-AC9C7436-58CA-4072-B5BF-BDDF024F17BCQ43819543-DE1CA14B-C952-42E2-B4C5-A5C274EF9CF2Q44671585-4DCF12A5-BCF8-4147-9826-B6A3C7CDEA2DQ46046292-B456DB33-0DE9-4297-B18E-E854AD729E97Q46100319-4F93FA0A-5E89-4E9E-9759-B46EB1910341Q47280422-CA6B7857-8195-4A12-9E9D-6ED5534BBCCEQ47294241-99162899-BC05-4A92-B5D0-B4AD21B4D3EAQ47334934-0E41467F-DD1C-4448-B14C-63DA721434FDQ47394375-88B4D4A5-035F-44AA-B49F-A16DA292765FQ47588223-A0A1D0D8-79F1-493D-B384-EDA4166B2C9DQ51083587-AEF944DF-1B6A-4303-A7D0-814154438A21Q51744738-E6993379-B172-40B7-918F-81AF90767D95Q51753660-6794E298-D8C8-4933-9DDD-68310E4A8FC5Q54687423-1B988CF2-C17E-4C11-9807-6A0FADDF5F50Q59487676-9118CB0D-0598-468D-B3D8-544E7E0B2B47Q59487677-9E64917F-6020-441F-AD85-82E9AD003D38Q59487699-B342885C-6EB9-4D0F-9870-00F256E0039E
P50
description
hulumtues
@sq
onderzoeker
@nl
researcher
@en
հետազոտող
@hy
name
Theodore C. Lystig
@ast
Theodore C. Lystig
@en
Theodore C. Lystig
@es
Theodore C. Lystig
@nl
Theodore C. Lystig
@sl
type
label
Theodore C. Lystig
@ast
Theodore C. Lystig
@en
Theodore C. Lystig
@es
Theodore C. Lystig
@nl
Theodore C. Lystig
@sl
altLabel
Ted Lystig
@en
Theodore C. Lystig
@en
Theodore Lystig
@en
prefLabel
Theodore C. Lystig
@ast
Theodore C. Lystig
@en
Theodore C. Lystig
@es
Theodore C. Lystig
@nl
Theodore C. Lystig
@sl
P1053
E-4149-2015
P106
P1153
8333929100
P1960
FIrSE0UAAAAJ
P21
P31
P3829
P496
0000-0002-4523-0761